| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.2 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as critical, has been found in Cisco IOS. The affected element is an unknown function of the component IPsec Phase 2 SA Anti-Replay. Performing a manipulation results in access control. This vulnerability is identified as CVE-2013-5548. There is not any exploit available. It is advisable to upgrade the affected component.
Details
A vulnerability classified as critical has been found in Cisco IOS (Router Operating System) (affected version unknown). This affects an unknown functionality of the component IPsec Phase 2 SA Anti-Replay. The manipulation with an unknown input leads to a access control vulnerability. CWE is classifying the issue as CWE-264. This is going to have an impact on confidentiality, and integrity. The summary by CVE is:
The IKEv2 implementation in Cisco IOS, when AES-GCM or AES-GMAC is used, allows remote attackers to bypass certain IPsec anti-replay features via IPsec tunnel traffic, aka Bug ID CSCuj47795.
The weakness was released 10/29/2013 as Cisco IOS Software Internet Key Exchange Version 2 Anti-replay Protection Disabled Vulnerability as confirmed advisory (Website). The advisory is shared at tools.cisco.com. The public release was coordinated with Cisco. This vulnerability is uniquely identified as CVE-2013-5548 since 08/22/2013. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1068 for this issue.
Upgrading eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability.
The vulnerability is also documented in the databases at SecurityFocus (BID 63426†), OSVDB (99149†) and Vulnerability Center (SBV-42146†). Further details are available at tools.cisco.com. Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Type
Vendor
Name
License
Website
- Vendor: https://www.cisco.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.5VulDB Meta Temp Score: 6.2
VulDB Base Score: 6.5
VulDB Temp Score: 6.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Access controlCWE: CWE-264
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Timeline
08/22/2013 🔍10/29/2013 🔍
10/29/2013 🔍
10/29/2013 🔍
10/31/2013 🔍
10/31/2013 🔍
11/01/2013 🔍
05/14/2017 🔍
Sources
Vendor: cisco.comAdvisory: Cisco IOS Software Internet Key Exchange Version 2 Anti-replay Protection Disabled Vulnerability
Status: Confirmed
Coordinated: 🔍
CVE: CVE-2013-5548 (🔍)
GCVE (CVE): GCVE-0-2013-5548
GCVE (VulDB): GCVE-100-11061
SecurityFocus: 63426
OSVDB: 99149
Vulnerability Center: 42146 - Cisco IOS IKEv2 Remote Information Leakage Vulnerability by Disabling Anti-Replay Protection, Medium
Misc.: 🔍
Entry
Created: 11/01/2013 10:55Updated: 05/14/2017 10:05
Changes: 11/01/2013 10:55 (44), 05/14/2017 10:05 (18)
Complete: 🔍
Committer:
Cache ID: 216:9D7:103

No comments yet. Languages: en.
Please log in to comment.